Weekly Update: New diabetes clinical trial (9 items)

New diabetes clinical trial: Pancreatic Duodenal Homeobox Factor-1 (PDX-1) and Neurogenin-3 (NGN-3) in Gestational Diabetes Published on: May 27, 2019 at 07:00PM Condition:   Gestational Diabetes Intervention:   Sponsors:   Materno-Perinatal Hospital of the State of Mexico;   Universidad Autonoma del Estado de Mexico Completed https://clinicaltrials.gov/ct2/show/NCT03964987?term=diabetes&sfpd_d=14 May 28, 2019 at 02:09PM via ClinicalTrials.gov New diabetes clinical trial: A Study to Look at How Safe NNC0268-0965 is in Healthy People and People With Type 1 Diabetes Published on: May 27, 2019 at 07:00PM Conditions:   Diabetes Mellitus, Type 1;   Healthy Volunteers Interventions:   Drug: NNC0268-0965;   Drug: Placebo;   Drug: insulin glargine Sponsor:   Novo Nordisk A/S Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03965013?term=diabetes&sfpd_d=14 May 28, 2019 at 02:09PM via ClinicalTrials.gov New diabetes clinical trial: NASH and Type 2 Diabetes: Role of the Receptor Activator of Nuclear Factor-κB (RANK) and Its Ligand (RANKL) Published on: May 30, 2019 at 07:00PM Conditions:   Diabetes type2;   NASH - Nonalcoholic Steatohepatitis;   NAFLD Intervention:   Biological: "Collection of additional blood tubes; Biobanking (plasma, liver tissue). Sponsor:   Assistance Publique - Hôpitaux de Paris Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03968354?term=diabetes&sfpd_d=14 May 30, 2019 at 03:05PM via ClinicalTrials.gov New diabetes clinical trial: Remote Monitoring of CGM Data in Pediatric Patients With Newly Diagnosed Type 1 Diabetes (T1D) Published on: May 30, 2019 at 07:00PM Condition:   Type 1 Diabetes Intervention:   Other: Integration with Epic Sponsor:   Stanford University Recruiting https://clinicaltrials.gov/ct2/show/NCT03968055?term=diabetes&sfpd_d=14 May 30, 2019 at 03:05PM via ClinicalTrials.gov New diabetes clinical trial: Effects of Progressive vs. Non-progressive Water-based Aerobic Training on Type 2 Diabetes Control: a Randomized Clinical Trial Published on: May 30, 2019 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Other: Progressive water-based aerobic training;   Other: Non-progressive aerobic training Sponsors:   Federal University of Rio Grande do Sul;   Coordenação de Aperfeiçoamento de Pessoal de Nível Superior. Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03967561?term=diabetes&sfpd_d=14 May 30, 2019 at 03:05PM via ClinicalTrials.gov New diabetes clinical trial: Contextualizing Evidence for Action on Diabetes Published on: May 30, 2019 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Intervention:   Other: Population survey with biological and physical measurements. Sponsors:   Universidad Miguel Hernandez de Elche;   European Research Council Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03968380?term=diabetes&sfpd_d=14 May 30, 2019 at 03:05PM via ClinicalTrials.gov New diabetes clinical trial: Evaluation of Early Retinal Nerve Injury in Type 2 Diabetes Patients Without Diabetic Retinopathy Published on: May 31, 2019 at 07:00PM Conditions:   Diabetes Mellitus;   Diabetic Retinopathy;   Nerve Injury Intervention:   Device: routine ophthalmic examination Sponsor:   Third Affiliated Hospital, Sun Yat-Sen University Recruiting https://clinicaltrials.gov/ct2/show/NCT03970161?term=diabetes&sfpd_d=14 May 31, 2019 at 03:03PM via ClinicalTrials.gov New diabetes clinical trial: A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus Published on: May 31, 2019 at 07:00PM Condition:   Non-alcoholic Steatohepatitis Interventions:   Drug: Placebo;   Drug: PF-06835919 Sponsor:   Pfizer Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03969719?term=diabetes&sfpd_d=14 May 31, 2019 at 03:03PM via ClinicalTrials.gov New diabetes clinical trial: A Study of MSDC-0602K to Assess Glycemic Control, Resolution of NASH, and Outcomes in Patients With Diabetes and NASH Published on: May 31, 2019 at 07:00PM Conditions:   Type2 Diabetes;   NASH - Nonalcoholic Steatohepatitis;   Nonalcoholic Steatohepatitis;   Non-Alcoholic Fatty Liver Disease Interventions:   Drug: MSDC-0602K;   Drug: Placebo oral tablet Sponsor:   Cirius Therapeutics, Inc. Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03970031?term=diabetes&sfpd_d=14 May 31, 2019 at 03:03PM via ClinicalTrials.gov